# Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

> **NCT04860505** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 20 (actual)

## Conditions studied

- Sexually Transmitted Diseases

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Biktarvy

## Key facts

- **NCT ID:** NCT04860505
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2022-05-09
- **Final completion:** 2022-05-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860505, "Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04860505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*